In a dramatic upsurge since the 1980s, cancer drugs now account for more than one-fourth of all new drug approvals in the United States since 2010, up from 4% a […]
With the clear understanding that using a placebo in randomized controlled clinical trials of therapies to treat hematologic malignancy and oncologic disease for which there is known effective therapy is […]
Sites, especially smaller and newer ones, don’t like to challenge sponsors during a clinical trial, and that’s understandable, says Melissa Holbrook, MSN, NP, vice president for operations with Velocity Clinical […]
Many clinical trial practices lose as much as 10% of potential revenue due to inaccurate, lost, or missing charges, says Noelle Gaskill, vice president for research operations with SignalPath. Clinical […]
Templates and checklists might not sound like the most powerful tools in the arsenal of good clinical trial performance, but don’t tell that to Christine Senn, PhD, CCRC, CPI, ACRP-CP, […]